| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Gain on exchange of warrants | - | 0 | - | - |
| Total other income | 670,734 | 649,024 | -532,265 | 1,195,577 |
| Net loss | -3,038,277 | -2,656,263 | -5,339,799 | -1,091,416 |
| Net loss per share - basic | -0.33 | -0.3 | -0.64 | -0.13 |
| Net loss per share - diluted | -0.33 | -0.3 | -0.64 | -0.13 |
| Weighted average common shares outstanding - basic | 9,116,172 | 8,740,382 | 8,357,143 | 8,121,499 |
| Weighted average common shares outstanding - diluted | 9,116,172 | 8,740,382 | 8,357,143 | 8,121,499 |
BioRestorative Therapies, Inc. (BRTX)
BioRestorative Therapies, Inc. (BRTX)